PL2134712T3 - Asparaginian kwasu 1-cyklopropylo-6-fluoro-7-(8-metoksyimino-2,6-diaza-spiro[3.4]okt-6-ylo)-4-okso-1,4-dihydro-[1,8]naftyrydyno-3-karboksylowego, sposób jego wytwarzania i zawierająca go przeciwdrobnoustrojowa kompozycja farmaceutyczna - Google Patents

Asparaginian kwasu 1-cyklopropylo-6-fluoro-7-(8-metoksyimino-2,6-diaza-spiro[3.4]okt-6-ylo)-4-okso-1,4-dihydro-[1,8]naftyrydyno-3-karboksylowego, sposób jego wytwarzania i zawierająca go przeciwdrobnoustrojowa kompozycja farmaceutyczna

Info

Publication number
PL2134712T3
PL2134712T3 PL08741351T PL08741351T PL2134712T3 PL 2134712 T3 PL2134712 T3 PL 2134712T3 PL 08741351 T PL08741351 T PL 08741351T PL 08741351 T PL08741351 T PL 08741351T PL 2134712 T3 PL2134712 T3 PL 2134712T3
Authority
PL
Poland
Prior art keywords
same
methoxyimino
naphthyridine
diaza
aspartate
Prior art date
Application number
PL08741351T
Other languages
English (en)
Inventor
Jei Man Ryu
Dong Rack Choi
Jin Yang
Sue Hye Yoon
Seung Hwan Kim
Sae Kwang Ku
Original Assignee
Dong Wha Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong Wha Pharm Co Ltd filed Critical Dong Wha Pharm Co Ltd
Publication of PL2134712T3 publication Critical patent/PL2134712T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
PL08741351T 2007-04-13 2008-04-14 Asparaginian kwasu 1-cyklopropylo-6-fluoro-7-(8-metoksyimino-2,6-diaza-spiro[3.4]okt-6-ylo)-4-okso-1,4-dihydro-[1,8]naftyrydyno-3-karboksylowego, sposób jego wytwarzania i zawierająca go przeciwdrobnoustrojowa kompozycja farmaceutyczna PL2134712T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20070036574 2007-04-13
PCT/KR2008/002106 WO2008127060A1 (en) 2007-04-13 2008-04-14 Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same
EP08741351.4A EP2134712B1 (en) 2007-04-13 2008-04-14 Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro [3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8] naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same

Publications (1)

Publication Number Publication Date
PL2134712T3 true PL2134712T3 (pl) 2014-01-31

Family

ID=39864109

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08741351T PL2134712T3 (pl) 2007-04-13 2008-04-14 Asparaginian kwasu 1-cyklopropylo-6-fluoro-7-(8-metoksyimino-2,6-diaza-spiro[3.4]okt-6-ylo)-4-okso-1,4-dihydro-[1,8]naftyrydyno-3-karboksylowego, sposób jego wytwarzania i zawierająca go przeciwdrobnoustrojowa kompozycja farmaceutyczna

Country Status (16)

Country Link
US (1) US8324238B2 (pl)
EP (1) EP2134712B1 (pl)
JP (1) JP5194105B2 (pl)
KR (1) KR100953271B1 (pl)
CN (1) CN101679416B (pl)
AU (1) AU2008239966C1 (pl)
BR (1) BRPI0810192C1 (pl)
CA (1) CA2683939C (pl)
CO (1) CO6251358A2 (pl)
DK (1) DK2134712T3 (pl)
EC (1) ECSP099736A (pl)
ES (1) ES2436140T3 (pl)
MX (1) MX2009011063A (pl)
PL (1) PL2134712T3 (pl)
PT (1) PT2134712E (pl)
WO (1) WO2008127060A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080109108A (ko) 2007-06-12 2008-12-17 (주)엘티엠에이피 휴대단말기용 스텝 힌지
KR101468659B1 (ko) * 2009-07-27 2014-12-05 주식회사 아리바이오 Ｒ-7-(3-아미노메틸-4-메톡시이미노-3-메틸-피롤리딘-1-일)-1-시클로프로필-6-플루오로-4-옥소-1,4-디히드로-[1,8]나프티리딘-3-카르복실산 ｌ-아스파르트산염, 이의 제조방법 및 이를 포함하는 항균용 약학적 조성물
KR101646324B1 (ko) * 2014-03-04 2016-08-05 동화약품주식회사 1-시클로프로필-6-플루오로-7-(8-메톡시이미노-2,6-디아자-스피로[3,4]옥트-6-일)-4-옥소-1,4-디히드로-[1,8]나프티리딘-3-카르복실산 디-아스파르트산염의 수화물 및 이를 포함하는 항균활성 조성물
CN103922987B (zh) * 2014-05-04 2016-09-28 苏州天马精细化学品股份有限公司 一种扎布沙星中间体及其合成方法
KR102213991B1 (ko) * 2014-05-20 2021-02-09 동화약품주식회사 개선된 자보플록사신의 제조방법
CN114894924B (zh) * 2022-04-21 2024-06-21 徐州医科大学 一种通过非衍生化gc-ms同时测定人血浆中4种抗癫痫药物的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8304117A1 (es) 1981-06-11 1983-02-16 Warner Lambert Co "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
JPS58966A (ja) * 1981-06-11 1983-01-06 ワ−ナ−−ランバ−ト・コンパニ− 抗菌性ナフチリジンおよびキノリン化合物の塩
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
KR960000223A (ko) * 1994-06-08 1996-01-25 김정순 신규한 피리돈 카르복실산 화합물을 함유한 수용액 및 이의 제조방법
KR100566346B1 (ko) * 1997-06-26 2006-11-10 동화약품공업주식회사 퀴놀론카르복실산 유도체
GB2356347B (en) * 1999-10-04 2002-05-15 John Carter Pharmaceutical compositions and their use
EP1492789B1 (en) 2002-04-08 2006-06-07 Pfizer Limited Tropane derivatives as ccr5 modulators

Also Published As

Publication number Publication date
EP2134712A4 (en) 2011-07-27
US8324238B2 (en) 2012-12-04
CO6251358A2 (es) 2011-02-21
US20100184795A1 (en) 2010-07-22
BRPI0810192B1 (pt) 2019-09-03
JP5194105B2 (ja) 2013-05-08
MX2009011063A (es) 2009-10-30
JP2010523649A (ja) 2010-07-15
BRPI0810192A2 (pt) 2014-12-30
AU2008239966B2 (en) 2011-11-10
AU2008239966A1 (en) 2008-10-23
CA2683939A1 (en) 2008-10-23
EP2134712A1 (en) 2009-12-23
DK2134712T3 (da) 2013-11-18
PT2134712E (pt) 2013-11-26
CN101679416B (zh) 2012-06-27
AU2008239966C1 (en) 2012-03-29
EP2134712B1 (en) 2013-08-21
KR100953271B1 (ko) 2010-04-16
ECSP099736A (es) 2010-02-26
BRPI0810192B8 (pt) 2019-09-10
HK1133881A1 (en) 2010-04-09
ES2436140T3 (es) 2013-12-27
CN101679416A (zh) 2010-03-24
BRPI0810192C1 (pt) 2021-05-25
KR20080092893A (ko) 2008-10-16
CA2683939C (en) 2012-06-19
WO2008127060A1 (en) 2008-10-23

Similar Documents

Publication Publication Date Title
IL221952A (en) Annotations 2, 3-Dihydro-1h - Indene-1-Il-7,2- Diazaspiro [5.3] Noonan and Pharmaceuticals Containing Them
IL215911A (en) 7-aryl-1,2,4-triazolo [3,4- a] derivatives, pharmaceutical preparations containing them and methods of preparation and uses thereof
IL207038A (en) History of Diazaspiro [5.5] Undecan, Pharmaceuticals Containing them, and their use in the preparation of drugs for the treatment or reduction of the risk of disease or inflammatory condition
IL220544A (en) History of n - (h1 - indazole - 4 - ram) imidazo [2,1 - a] pyridine - 3 - carboxamide, processes for their preparation and pharmaceutical preparations containing them
IL211693A (en) Annotations3 –– Cyano – 6– (Amino Converted) –8– (Optionally Converted Amino) –Imidazo [2,1– b] Pyridazine and Pharmaceuticals Containing Them
IL219424A (en) Imidazo derivative [b – 1,2] pyridazine, combinations, distant preparations containing them and process for their preparation and use as pde10 inhibitors
ZA201100429B (en) Novel imidazo [1,2-a]pyrimidine derivatives,method for the preparation thereof,use thereof as medicaments,pharmaceutical compositions and novel use in particular as met inhibitors
IL215910A (en) Derivatives 4,2,1 - Triazolo [3,4 – a] Pyridine, pharmaceutical preparations contain them and processes for their preparation and their uses for the preparation of drugs for the treatment of diseases of the central nervous system
IL205977A (en) Annals of 5-phenylamino-imidazo [5,1- a] (pyridine / pyrazine) and pharmaceuticals containing them
IL206395A (en) N- Heterocyclic-7-Oxo-6-Sulphoxy-6,1-Diazabicyclo [1.2.3] Octane-2-Carboxamides and Pharmaceuticals Containing Them
IL182876A (en) Annotations 7 - (aryl / heteroaryl) - 2 - cyclohexyl - 7,2 - diazaspiro [5.4] decan - 1 - and pharmaceutical preparations containing them
WO2012143416A3 (en) 7 - (3,5 - dimethyl - 4 - isoxazolyl) - 8 - (methyloxy) - 1h - imidazo [4,5 -c] quinoline derivatives
ZA200800818B (en) Plant support formulation, vehicle for the delivery and translocation of phytologically beneficial substances and compositions containing same
IL196653A (en) Kempthetine derivatives, preparations containing them, their uses for drug preparation and processes for their preparation
IL210688A0 (en) Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors
IL210708A0 (en) Imidazo [1,2-a]pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors
IL205189A (en) 7,6-dihydro-h5-imidazo [2,1- α] imidazole-3-carboxamide and their pharmaceutical preparations
PL2134712T3 (pl) Asparaginian kwasu 1-cyklopropylo-6-fluoro-7-(8-metoksyimino-2,6-diaza-spiro[3.4]okt-6-ylo)-4-okso-1,4-dihydro-[1,8]naftyrydyno-3-karboksylowego, sposób jego wytwarzania i zawierająca go przeciwdrobnoustrojowa kompozycja farmaceutyczna
WO2008062436A3 (en) Antimicrobial derivatives of anacardic acid and process for preparing the same
IL178425A0 (en) Carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL206673A0 (en) Imidazo[1,2-a]pyridine-2-carboxamide derivatives, their preparation and their therapeutic application
HUP0700395A2 (en) Substituted [1,2,4] triazolo [1,5-a] quinolines, process for their preparation, pharmaceutical compositions thereof, and intermediates
IL206671A0 (en) N-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
SI1954251T1 (sl) Sestavek s počasnim sproščanjem, ki ima kot aktivno učinkovino Fe sol, postopek njegove priprave in uporabe
IL206669A0 (en) 6-HETEROCYCLIC IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF